AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Stock Analysis

What AgomAb Therapeutics N.V. American Depositary Shares does

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally administered, gastrointestinal-restricted small molecule inhibitor targeting ALK5 or TGFßR1, designed to treat Fibrostenosing Crohn's disease and presently undergoing Phase 2a clinical trials. Also in development is AGMB-447, an inhaled small molecule that similarly inhibits ALK5 or TGFßR1, intended for idiopathic pulmonary fibrosis and currently in Phase 1 clinical studies. Furthermore, the company is advancing AGMB-101, a monoclonal antibody designed to mimic HGF. This agent exerts its effects through the agonism or stimulation of the MET receptor, having demonstrated both antifibrotic and regenerative capabilities in preclinical models. Established in 2017, AgomAb Therapeutics maintains its headquarters in Antwerp, Belgium.

Key metrics

ETFs linked to AGMB

Broad-market and Healthcare sector ETFs an investor holding AgomAb Therapeutics N.V. American Depositary Shares is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AGMB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for AgomAb Therapeutics N.V. American Depositary Shares?

AgomAb Therapeutics N.V. American Depositary Shares trades under the ticker AGMB on NASDAQ.

Which exchange is AGMB listed on?

AGMB is listed on NASDAQ.

What sector does AgomAb Therapeutics N.V. American Depositary Shares operate in?

AgomAb Therapeutics N.V. American Depositary Shares is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AGMB in a portfolio?

PortView shows AGMB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.